Huntington Disease (HD) is an incurable autosomal dominant single gene
neurodegenerative disorder. Typical onset is between 30 and 40 years and characterised by …

BACKGROUND Huntington's disease (HD) is an autosomal dominant neurodegenerative
late onset disorder. This review of reproductive options aims to increase reproductive …

Most of the research on reproduction in those at risk for Huntington Disease (HD) has
focused on the impact of genetic testing on reproductive decision-making. The main goal …

We explored how individuals at-risk for HD who have or have not been tested make
reproductive decisions and what factors are involved. We interviewed 21 individuals (8 with …

The aim of this study was to describe reproductive decisions in mutation carriers after
predictive testing for Huntington's disease (HD) and to identify factors that play a role in …

A retrospective study examined both pre‐and post‐result reproductive decision making for
281 people at risk for Huntington's disease aged 18–45 years who had undergone …

This European collaborative study addresses the question whether a predictive test result for
Huntington's disease (HD) has an effect on subsequent reproduction by comparing carriers …

Rates of genetic testing in Huntington disease (HD) are lower than was predicted before
direct DNA testing became available. Clinicians often do not have in‐depth conversations …

Research indicates that health care professionals' attitudes may affect patients' decisions
regarding prenatal Huntington Disease testing, but few studies have sampled genetic …

Predictive testing for Huntington disease (HD) has been available in the United States (US)
since 1987, and the Indiana University Predictive Testing Program has been providing this …